Found: 2
Select item for more details and to access through your institution.
Modified bi‐weekly cetuximab‐cisplatin and 5‐FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients.
- Published in:
- Cancer Reports, 2022, v. 5, n. 3, p. 1, doi. 10.1002/cnr2.1479
- By:
- Publication type:
- Article
The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 5, p. 1335, doi. 10.1007/s00432-021-03538-1
- By:
- Publication type:
- Article